Clinical Trial Update: Effect of Dexmedetomidine on Plasmatic Cortisol Response in Transsphenoidal Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating whether dexmedetomidine alters plasmatic cortisol response during transsphenoidal surgery in patients with pituitary neoplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pituitary Neoplasms

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Pontificia Universidad Catolica de Chile | Conditions: Pituitary Neoplasms | Phase 4 | Status: UNKNOWN